🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting discussions last week! 🔬 Dr. Nicla and Dr. Anna_Tcc shared their latest findings at 6th WORKSHOP IRE (IRE ISG IFO ) ON TRANSLATIONAL ONCOLOGY! #research #immunology #preclinicalmodels #tumor #microenvironment #lungcancer 🫁

We're ready for the Nibit Meeting in Palermo tomorrow! Excited to present our recent data 📊 🔬🧫

Here we are! 🥳

Today, Alessandra Metelli, PhD, our newest group member, delivered an insightful talk on the role of #TissueFactor in #CancerCell . Fantastic work! 💪🏻🔬 #NibitMeeting #Day2 #CancerResearch

Today, Dr. Nicla presented exciting new data on integrating spatial transcriptomics with organotypic tissue slices to chart the tumor immune microenvironment in #NSCLC. 🔬Outstanding talk - well done, Nicla! 👏#Immunology #TumorMicroenvironment #Nibitmeeting

I had such an amazing time representing the TLS field Nibit 2024 with Drs. Sautés Fridman and Dimberg. Thank you to the organizing committee and my dear friend, Dr. Paola Nistico for the invitation. I love Palermo 🇮🇹 #TLS

Dr. Di Modugno & Dr. Di Carlo, Dr. Rosado, Dr. Melchionna, Dr. Palermo & Dr. Frisullo, and Dr. Anna_Tcc presented their latest data during the poster Session at the Nibit Meeting in Palermo! Fantastic work, everyone! 👏 #NibitMeeting #CancerResearch #Immunology

The #NIBIT meeting in Palermo was incredible, with outstanding speakers and insightful discussions! And of course, the fantastic food made it even better. Amazing time all around!

Congratulazioni a Paola Nisticò, Resp. Immunologia e immunoterapia dei tumori #ReginaElena eletta nuova Presidente NIBIT, Network Italiano per la Bioterapia e Immunoterapia dei Tumori: ifo.it/2024/10/28/xxi… TheNisticòLab Gennaro Ciliberto

Tomorrow I will be voting like science and health depends on it. Because it does.

Today at IRE ISG IFO Casanova Acebes Lab talking about the complexity of macrophages in tumour microenvironment. Such a brilliant and inspiring young PI with an entusiastic view on the macrophages world. A pleasure for young researchers!

Read here this interesting Meeting Report published on JECCR👇 #CancerOrganoids as reliable disease models to drive clinical development of novel therapies jeccr.biomedcentral.com/articles/10.11… #PrecisionMedicine #Patientderived3Dculturemodel #PreclinicalModels #CancerSpheroid

My Uber driver found out I’m a cancer research and told me about his father who has been 4 yrs cancer free thanks to a-PD1 immunotherapy (Nivo). Mentioned how his father got to see his two sons married, meet his grandchildren. As a scientist, these stories are very inspiring

Happy Valentine’s Day! Here’s a heart-shaped, stem cell-derived cardiac organoid from Sean Escopete in our lab. Our mini-hearts beat for you! ❤️🫀

I commenti di oggi: Se Trump distrugge la ricerca [di Alberto Mantovani] #16marzo repubblica.it/commenti/2025/…

European scientists stand united with our American colleagues. We support the #StandUpForScience movement and advocate for sustained funding and policies that empower scientific research worldwide. #sciencenotsilence #scienceforall

🚨 Just published in Journal for ImmunoTherapy of Cancer: our report on spatial transcriptomics of a resectable NSCLC after neoadjuvant chemo-io. A great multidisciplinary effort by TheNisticòLab and IRE ISG IFO! Looking forward to many collaborations in this field. jitc.bmj.com/content/13/5/e…

Precision medicine for lung cancer 🫁: a new case report from our institute IRE ISG IFO highlights B cells as crucial players in the response to neoadjuvant chemo-immunotherapy therapy. Filippo Gallina Nicla Paola Nistico

🧪 Studio ricercatrici IRE Tumore del polmone: scoperte “fabbriche di difesa immunitaria” 🛡️ che predicono la risposta alla chemio-immunoterapia. Una paziente con metastasi cerebrale ha ottenuto risposta completa e lunga sopravvivenza. 🔬 Scopri di più: ifo.it/2025/05/21/tum…

I think this might be my best slide yet… #IYKYK Prostate Cancer Foundation